Compare Wegovy And Mounjaro - Both Available Today
Wegovy And Mounjaro In Stock UK - Immediate Availability Confirmed
Supply shortages have plagued weight management treatments across the UK, but EverydayMeds maintains robust stock levels for both Wegovy and Mounjaro through direct partnerships with manufacturers. Our pharmacy holds all five Wegovy doses (0.25mg through 2.4mg) in temperature-controlled storage, alongside full Mounjaro supplies, ensuring patients can start treatment without delays. Unlike other providers facing intermittent shortages, our GPhC-registered facility (#9012878) processes orders within 24 hours of prescriber approval.
The difference in availability stems from our proactive inventory management and established relationships with Novo Nordisk and Eli Lilly. When you order Wegovy or Mounjaro through our platform, you're accessing Stock Available rather than joining lengthy waitlists that have become commonplace elsewhere. This reliability proves crucial for patients requiring consistent medication supply to maintain their weight management progress throughout the dose escalation phases.
Wegovy And Mounjaro Pricing - Transparent Costs With Discount Codes
Understanding the financial commitment helps inform your choice between Wegovy and Mounjaro treatments. Wegovy single pens start at £79.99 for the 0.25mg starter dose, progressing to £209.99 for the 2.4mg maintenance dose, with new customer discount code FIRST40 applied at checkout. Our Getting Started bundles, like the Intro Duo combining 0.25mg and 0.5mg doses, cost £169.99 and eliminate the need for separate orders during initial treatment weeks. Returning customers benefit from the DOSE25 discount code for ongoing prescriptions.
Bundle pricing reflects convenience rather than pure savings, providing Reliable Supply continuity and reducing delivery frequency. The Ultimate Stability Trio offers three 2.4mg maintenance doses for £649.99, ensuring uninterrupted treatment for patients who've reached their target dose. All prices include prescriber consultation, clinical assessment, and next-day cold-chain delivery, making the total cost transparent from the outset without hidden fees or consultation charges.
Clinical Evidence For Wegovy And Mounjaro Effectiveness
Both treatments demonstrate significant efficacy in clinical trials, though direct comparisons remain limited due to different study designs and patient populations. In the STEP trials, patients taking Wegovy alongside diet and exercise achieved average weight reductions of approximately 15% at 68 weeks, as reported by Wilding et al., NEJM, 2021. The STEP programme encompassed over 4,500 participants across multiple studies, establishing semaglutide's role in sustainable weight management.
Mounjaro's SURMOUNT trials showed comparable results with tirzepatide's dual GIP and GLP-1 receptor mechanism, though these studies involved different baseline characteristics and endpoints. Both treatments require adherence to reduced-calorie diets and increased physical activity to achieve optimal outcomes, and individual responses may vary significantly from trial averages.
How Wegovy And Mounjaro Work - Different Mechanisms Explained
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the natural incretin hormone responsible for post-meal satiety signals. This mechanism reduces appetite by acting on brain centres that control hunger and fullness, helping patients feel satisfied with smaller portion sizes. Mounjaro utilises tirzepatide, a dual agonist targeting both GLP-1 and GIP receptors, potentially offering enhanced metabolic effects through its dual pathway approach. Both treatments slow gastric emptying, prolonging the feeling of fullness after meals and reducing the frequency of hunger signals. The weekly injection schedule for both medications helps maintain consistent therapeutic levels, supporting sustained appetite control throughout treatment. Your prescriber can explain which mechanism might align better with your individual metabolic profile and weight management goals.
Ordering Wegovy And Mounjaro - Streamlined Process
Our clinical assessment takes approximately 3 minutes to complete, covering medical history, current medications, and weight management goals relevant to both Wegovy and Mounjaro prescribing. Qualified prescribers review applications within 3 working days (express 24-hour service available), ensuring thorough evaluation of your suitability for either treatment option. Once approved, medications ship via next-day delivery using specialised cold-chain logistics to maintain the 2-8°C temperature requirements throughout transit. All packages include insulated packaging with temperature monitoring to ensure medication integrity upon arrival. The entire process from assessment to delivery typically completes within 4-5 working days, providing faster access than traditional GP referral pathways for weight management treatments.
Storage Requirements For Wegovy And Mounjaro
Both treatments require refrigerated storage at 2-8°C before first use, but Wegovy offers superior travel convenience with its 6-week room temperature stability compared to Mounjaro's 21-day limit. The FlexTouch pen design used for Wegovy provides intuitive dose selection and injection, while Mounjaro utilises a similar pre-filled pen system for patient convenience. Dose escalation remains mandatory for both treatments, starting with lower doses to minimise gastrointestinal side effects before progressing to therapeutic levels. Each pen contains 4 doses for weekly administration, requiring patients to track their progression through the escalation schedule. Proper storage and handling ensure medication potency throughout the treatment course, making the extended room temperature stability particularly valuable for patients with active lifestyles or frequent travel.
UK Supply Chain Reliability For Wegovy And Mounjaro
Supply chain disruptions have created significant challenges across UK pharmacies, particularly affecting Wegovy availability since its launch. EverydayMeds has established direct distribution agreements with both Novo Nordisk and Eli Lilly, bypassing traditional wholesaler networks that often experience stock shortages during high-demand periods. This approach ensures consistent availability of both Wegovy and Mounjaro, regardless of broader market supply fluctuations that have left many patients unable to continue their prescribed treatments.
Our inventory management system tracks usage patterns and automatically reorders stock before depletion, preventing the treatment interruptions that can derail weight management progress. When other pharmacies display "out of stock" notices, our reliable supply chain maintains therapeutic continuity for existing patients while accepting new prescriptions without delay. This stability proves particularly crucial during the initial months of treatment when dose escalation requires timely access to progressively higher strength preparations.
Choose Between Wegovy And Mounjaro With Expert Guidance
The decision between Wegovy and Mounjaro involves multiple factors including individual response patterns, storage requirements, and specific metabolic considerations that our prescribers evaluate during consultation. Both treatments are available immediately through our platform, eliminating supply-related pressure from your treatment choice and allowing purely clinical decision-making. Your assessment results help determine which mechanism might provide optimal outcomes based on your medical history, current medications, and weight management objectives. Start your clinical assessment today using discount code FIRST40 for new customers, with both prescription-only medicines ready for next-day delivery once approved. Visit https://everydaymeds.co.uk/collections/wegovy to begin your consultation and access expert prescriber guidance in choosing between these proven weight management treatments.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
